Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Aaron Moberly

Otology & Neurotology Nashville, TN Medical Doctor

NPI 1083872022 CMS profile 1219934

3601 The Vanderbilt Clinic, Nashville, TN 37232

Open in the dashboard

General payments

$6,728

21 records reported · program years 2019–2024

Research payments

$1,032

Paid to them · 4 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,754 paid to institutions, not to them · program years 2019–2021

Through program year 2024, Aaron Moberly of Nashville, TN is reported in the CMS Open Payments database as having received $6,728 across 21 general payments and $1,032 in research payments paid to them. Separately, studies naming them as principal investigator received $10,754 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 76th percentile of Otology & Neurotology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $857 2
2023 General $161 3
2022 General $3,248 8
2021 General $2,171 4
2019 General $291 4
2019 Research $1,032 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Moberly
  • Otology & Neurotology median
  • Middle half of Otology & Neurotology
  • National median

In program year 2025, general payments to Aaron Moberly were reported at $0. Among 280 Otology & Neurotology profiles paid that year, the median was $411 and the middle half received between $148 and $1,608.

Show as a table
Year Aaron Moberly Otology & Neurotology median Middle half National median
2019 $291 $349 $117–$1,358 $163
2020 $0 $118 $58–$325 $114
2021 $2,171 $186 $81–$600 $132
2022 $3,248 $290 $129–$938 $149
2023 $161 $335 $119–$978 $160
2024 $857 $399 $138–$1,384 $164
2025 $0 $411 $148–$1,608 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. MED-EL Corporation $3,123 8 payments
  2. Cochlear Americas $2,748 11 payments
  3. Amgen Inc. $751 1 payment
  4. Advanced Bionics, LLC $106 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Travel and Lodging $2,851 4 payments
  2. Consulting Fee $2,751 2 payments
  3. Food and Beverage $1,126 15 payments
Products named General payments · program years 2019–2024
  1. Mi1250 SYNCHRONY 2 FLEXsoft $3,076 7 payments
  2. BCI 602 Kit $3,029 6 payments
  3. ADHEAR Professional Kit $2,371 4 payments
  4. Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode $2,270 5 payments
  5. Baha BI300 implant 4 mm $2,124 3 payments
  6. Cochlear Osia OSI200 Implant $2,124 3 payments
  7. TAVNEOS $751 1 payment
  8. BAHA Implantable hearing solution $333 4 payments
  9. Nucleus $291 4 payments
  10. Baha Implantable hearing solution $291 4 payments
  11. Other $721 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Cochlear Americas $1,032 4 payments

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$15,922

Medicare's payments for the services billed

Medicare patients

71

Average age 74

Services billed

107

43 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 59%
Diabetes 31%
Ischemic heart disease 28%
Osteoporosis 24%
Depression 18%
Atrial fibrillation 17%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TAVNEOS
  • Amgen Inc. $751
$751 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otology & Neurotology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record